Bold and BRASH
As we
all know, one of the cornerstones of nephrology is the intimate relationship
between the ever-present and masterfully made kidneys and that other thing less
important thing a little higher up that pumps blood (remember this is a
nephrology blog.) In all seriousness though, we can never forget that renal
disease inevitably begets cardiac disease and vice versa and must always be
vigilant about that relationship. And of course, there are many ways that this
phenomenon called cardiorenal syndrome comes to exist. I want to touch upon a
special phenomenon called BRASH syndrome.
BRASH
syndrome which stands for Bradycardia,
Renal Failure, AV-nodal blocking agents, Shock,
Hyperkalemia is a phenomenon that
usually occurs (but not necessarily required) in the setting of AV-nodal
blockers that cause bradycardia which leads to poor renal perfusion which
progresses to renal failure which causes hyperkalemia which in turn leads to
worsening bradycardia and the cycle continues. It is an incredibly interesting
scenario in that seemingly unrelated or previously thought unrelated components
are very closely related.
Looking
back, people have described a phenomenon whereby people who have bradycardia
end up in renal failure. Physiologically
this makes perfect sense when thinking about cardiac output as seen below:
Cardiac Output = Heart Rate X Stroke Volume
As
heart rate drops stroke volume is not always enough to keep up with cardiac
output especially if a patient has pre-existing cardiac disease and cannot
mount a
good volume response to drop in HR. Patient’s with kidney disease
are also susceptible to this. Eventually, patients will go into shock from
this perpetual cycle.
Treatment
for this disease really hinges on two things: restoring sinus rhythm at
appropriate which should in turn start to relieve acute kidney injury by
restoring renal perfusion and temporizing patients with hyperkalemia. In most
cases invasive measures like transvenous pacing are NOT necessary unless
advanced heart blocks are present however medications such as dopamine or
isoproterenol or even epinephrine can be used to try and restore perfusion to
the kidney. If patient’s have suspected AV-nodal blocking agent toxicity even
conventional methods like glucagon or insulin drip are not usually necessary.
Next, IV calcium should be used to help stabilize cardiac membrane to prevent
further bradycardia. Then, kaluresis is important as well to help stop
bradycardia. If a patient is hypovolemic fluid resuscitation is very important
and Lactated Ringers or Bicarbonate infusion can be used based on the patient’s
acid-base status. Also, if patient is anuric, diuretics can be tried to help
open up kidneys to eliminate potassium however if patient’s do not respond,
dialysis may be required to intervene in this cycle to prevent further
bradyarrhythmia and/or arrest.
Overall,
BRASH syndrome is a sometimes-overlooked entity which can be resolved quickly
if caught early and usually can prevent worsening renal and cardiac disease.
Major
Take Away Points:
1)
BRASH
Syndrome - Bradycardia, Renal Failure, AV-nodal
blocking agents, Shock, Hyperkalemia
2)
Vicious
cycle where one entity (sometimes started by AV-nodal blockers) usually leads
to another
3)
Occurs
due to drop in cardiac output from bradycardia without appropriate response of
stroke volume to compensate
4)
AKI
occurs in low flow state causing renal hypoperfusion leading to pre-renal state
and possible ATN causing build-up of potassium
5)
Treatment
relies on managing bradycardia to restore renal perfusion, and cardiac membrane
stabilization along with kaluresis
For
more information, there is a great review here:
image courtesy: https://spongebob.fandom.com/wiki/Bold_and_Brash
Post
by
Rushang Parikh, MD
Rushang Parikh, MD
No comments:
Post a Comment